MBD3L1
gene geneOn this page
Summary
MBD3L1 (methyl-CpG binding domain protein 3 like 1, HGNC:15774) is a protein-coding gene on chromosome 19p13.2, encoding Methyl-CpG-binding domain protein 3-like 1 (Q8WWY6). Transcriptional repressor.
This gene encodes a protein that is related to methyl-CpG-binding proteins but lacks the methyl-CpG binding domain. The protein is localized to discrete areas in the nucleus, and expression appears to be restricted to round spermatids, suggesting that the protein plays a role in the postmeiotic stages of male germ cell development.
Source: NCBI Gene 85509 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_001393532
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15774 |
| Approved symbol | MBD3L1 |
| Name | methyl-CpG binding domain protein 3 like 1 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000170948 |
| Ensembl biotype | protein_coding |
| OMIM | 607963 |
| Entrez | 85509 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000305625, ENST00000595891
RefSeq mRNA: 4 — MANE Select: NM_001393532
NM_001393532, NM_001393533, NM_001393534, NM_145208
CCDS: CCDS12209
Canonical transcript exons
ENST00000595891 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002998889 | 8840915 | 8840999 |
| ENSE00003031999 | 8842658 | 8843319 |
| ENSE00003108041 | 8832377 | 8832522 |
Expression profiles
Bgee: expression breadth broad, 38 present calls, max score 92.33.
Top tissues by expression
219 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.33 | gold quality |
| left testis | UBERON:0004533 | 86.07 | gold quality |
| sperm | CL:0000019 | 85.17 | gold quality |
| right testis | UBERON:0004534 | 84.73 | gold quality |
| testis | UBERON:0000473 | 83.30 | gold quality |
| buccal mucosa cell | CL:0002336 | 81.06 | silver quality |
| right uterine tube | UBERON:0001302 | 72.35 | gold quality |
| adult organism | UBERON:0007023 | 62.28 | gold quality |
| oviduct epithelium | UBERON:0004804 | 61.80 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 59.11 | gold quality |
| fallopian tube | UBERON:0003889 | 57.57 | gold quality |
| myocardium | UBERON:0002349 | 55.17 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 54.59 | gold quality |
| pericardium | UBERON:0002407 | 54.13 | gold quality |
| lower lobe of lung | UBERON:0008949 | 52.74 | silver quality |
| substantia nigra pars reticulata | UBERON:0001966 | 52.39 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 50.87 | gold quality |
| oocyte | CL:0000023 | 50.21 | gold quality |
| body of pancreas | UBERON:0001150 | 49.59 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.21 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 48.35 | gold quality |
| granulocyte | CL:0000094 | 46.21 | silver quality |
| upper leg skin | UBERON:0004262 | 45.95 | silver quality |
| biceps brachii | UBERON:0001507 | 45.39 | gold quality |
| amniotic fluid | UBERON:0000173 | 44.66 | gold quality |
| synovial joint | UBERON:0002217 | 44.03 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 43.88 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 43.79 | gold quality |
| medulla oblongata | UBERON:0001896 | 43.39 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.96 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex (PMID:15456747)
- These factors lead to a binding affinity hierarchy of p66alpha for the different MBD2 homologues (MBD2 approximately MBD3 > MBD3L1 approximately MBD3L2). (PMID:23239876)
- These and other approaches identified the Nucleosome Remodeling Deacetylase (NuRD) and Chromatin Assembly Factor 1 (CAF-1) complexes as necessary for DUX4 repression in human skeletal muscle cells and induced pluripotent stem (iPS) cells.Furthermore, DUX4-induced expression of MBD3L proteins partly relieved this repression in FSHD muscle cells. (PMID:29533181)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mbd3a | ENSDARG00000061774 |
| mus_musculus | Mbd3l1 | ENSMUSG00000038691 |
| rattus_norvegicus | Mbd3l1 | ENSRNOG00000006363 |
| drosophila_melanogaster | MBD-like | FBGN0027950 |
Paralogs (8): MBD3 (ENSG00000071655), MBD2 (ENSG00000134046), MBD1 (ENSG00000141644), MBD3L3 (ENSG00000182315), MBD3L2B (ENSG00000196589), MBD3L4 (ENSG00000205718), MBD3L2 (ENSG00000230522), MBD3L5 (ENSG00000237247)
Protein
Protein identifiers
Methyl-CpG-binding domain protein 3-like 1 — Q8WWY6 (reviewed: Q8WWY6)
All UniProt accessions (1): Q8WWY6
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor.
Subcellular location. Nucleus.
Tissue specificity. Highly expressed in testis. Detected at low levels in pancreas. Not detected in the other tissues tested.
Domain organisation. The N-terminal half of the protein mediates transcription repression.
Miscellaneous. Does not bind methylated DNA. The MBD3L proteins are encoded by strongly repeated regions of the 19p13 chromosome. The exact number of functional copies is unclear, and some of them may represent pseudogenes.
Similarity. Belongs to the MBD3L family.
RefSeq proteins (4): NP_001380461, NP_001380462, NP_001380463, NP_660209 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025884 | MeCpG-bd_2/3_C_dom | Domain |
| IPR032343 | MBD2/MBD3_p55-bd | Domain |
Pfam: PF14048, PF16564
UniProt features (3 total): chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WWY6-F1 | 66.83 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9937850 | NuRD complex assembly |
MSigDB gene sets: 48 (showing top):
ROVERSI_GLIOMA_COPY_NUMBER_UP, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC, GOBP_DNA_METHYLATION_DEPENDENT_CONSTITUTIVE_HETEROCHROMATIN_FORMATION, GOBP_CHROMATIN_REMODELING, GOBP_HETEROCHROMATIN_ORGANIZATION, GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, chr19p13, GOMF_METHYL_CPG_BINDING, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, SRC_UP.V1_UP, CHAF1B_TARGET_GENES, DIDO1_TARGET_GENES, ELF2_TARGET_GENES
GO Biological Process (2): negative regulation of transcription by RNA polymerase II (GO:0000122), DNA methylation-dependent constitutive heterochromatin formation (GO:0006346)
GO Molecular Function (2): methyl-CpG binding (GO:0008327), protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| CHD3, CHD4, CHD5 subfamily | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| constitutive heterochromatin formation | 1 |
| nucleotide binding | 1 |
| sequence-specific DNA binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
386 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MBD3L1 | MECP2 | P51608 | 649 |
| MBD3L1 | OR2Z1 | Q8NG97 | 582 |
| MBD3L1 | PRAMEF5 | Q5TYX0 | 474 |
| MBD3L1 | ZNF558 | Q96NG5 | 469 |
| MBD3L1 | OR1M1 | Q8NGA1 | 468 |
| MBD3L1 | GATAD2A | Q86YP4 | 383 |
| MBD3L1 | PRAMEF15 | P0DUQ1 | 370 |
| MBD3L1 | DNMT1 | P26358 | 323 |
| MBD3L1 | GATAD2B | Q8WXI9 | 292 |
| MBD3L1 | MBD4 | O95243 | 283 |
| MBD3L1 | ACCSL | Q4AC99 | 277 |
| MBD3L1 | SHROOM1 | Q2M3G4 | 276 |
| MBD3L1 | ACTL9 | Q8TC94 | 268 |
| MBD3L1 | TRDMT1 | O14717 | 268 |
| MBD3L1 | H3Y2 | P0DPK5 | 255 |
IntAct
133 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GATAD2A | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| EFHC1 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF77 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF76 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ANKS1A | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AIRIM | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNAPC5 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MBD3L1 | NEK6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MLH1 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MBD3L1 | GTPBP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DTX2 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MBD3L1 | NXF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MBD3L1 | NDUFAF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EXOC8 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SUOX | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BOLA2-SMG1P6 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MBD3L1 | CTNNA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAPPC2 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MBD3L1 | UBL5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNRPB | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (123): RBBP4 (Affinity Capture-MS), RBBP7 (Affinity Capture-MS), HDAC1 (Affinity Capture-MS), HDAC2 (Affinity Capture-MS), GATAD2B (Affinity Capture-MS), GATAD2A (Affinity Capture-MS), CHD3 (Affinity Capture-MS), CHD4 (Affinity Capture-MS), ZNF521 (Affinity Capture-MS), ZNF423 (Affinity Capture-MS), MTA2 (Affinity Capture-MS), MTA1 (Affinity Capture-MS), MTA3 (Affinity Capture-MS), CDK2AP1 (Affinity Capture-MS), BEND7 (Affinity Capture-MS)
ESM2 similar proteins: A2A7Y5, A2AFS9, A2AIW0, A6NFA0, A6NMK8, A9JRX0, B2RQL2, C3VD30, P54257, Q0VET5, Q0VG85, Q14B48, Q2M243, Q2YDE2, Q3V036, Q3V0C3, Q3V0M2, Q4R739, Q5E9L4, Q5PQS2, Q5R9L2, Q60664, Q6AYH0, Q6AYP4, Q6DF94, Q6GQV1, Q6NZK5, Q6P1D7, Q6ZRS4, Q6ZVD7, Q70YC5, Q7L3B6, Q7M6U3, Q7Z572, Q86WZ0, Q8BG89, Q8CCC3, Q8CCG1, Q8CH09, Q8IYA8
Diamond homologs: A0A1B0GVZ6, A6NDZ8, A6NE82, A6NJ08, O95983, Q8NHZ7, Q8WWY6, Q9D9H3, Q9UBB5, Q9Z2D8, Q9Z2E1, O95243, P51608, Q00566, Q95LG8, Q9UIS9, Q9Z2D6, Q9Z2D7, Q9Z2E2, Q9FZP6, Q9LTJ1, Q9LYB9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
658 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:8832520:GGG:G | donor_gain | 0.9800 |
| 19:8832521:GGG:G | donor_gain | 0.9800 |
| 19:8832519:GGGG:G | donor_gain | 0.9700 |
| 19:8832520:GGGG:G | donor_gain | 0.9700 |
| 19:8832521:GG:G | donor_gain | 0.9700 |
| 19:8832522:GG:G | donor_gain | 0.9700 |
| 19:8832494:T:G | donor_gain | 0.9500 |
| 19:8832523:GT:G | donor_loss | 0.9500 |
| 19:8832524:T:A | donor_loss | 0.9500 |
| 19:8832482:G:GG | donor_gain | 0.9100 |
| 19:8832511:G:T | donor_gain | 0.9100 |
| 19:8832462:G:GT | donor_gain | 0.9000 |
| 19:8832481:A:AG | donor_gain | 0.9000 |
| 19:8840911:GCA:G | acceptor_gain | 0.9000 |
| 19:8840985:C:T | donor_gain | 0.9000 |
| 19:8832511:G:GT | donor_gain | 0.8900 |
| 19:8832523:G:GG | donor_gain | 0.8900 |
| 19:8842656:A:AG | acceptor_gain | 0.8900 |
| 19:8842657:G:GG | acceptor_gain | 0.8900 |
| 19:8842657:GT:G | acceptor_gain | 0.8800 |
| 19:8832525:A:AG | donor_loss | 0.8700 |
| 19:8840911:GCAGT:G | acceptor_gain | 0.8700 |
| 19:8840997:GTG:G | donor_gain | 0.8700 |
| 19:8840911:GC:G | acceptor_gain | 0.8000 |
| 19:8841211:T:TA | acceptor_gain | 0.8000 |
| 19:8832478:C:G | donor_gain | 0.7700 |
| 19:8832529:T:TA | donor_gain | 0.7700 |
| 19:8832530:T:A | donor_gain | 0.7700 |
| 19:8842972:TAG:T | acceptor_gain | 0.7700 |
| 19:8832467:GTTCT:G | donor_gain | 0.7500 |
AlphaMissense
1258 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:8842781:T:C | F35L | 0.924 |
| 19:8842783:C:A | F35L | 0.924 |
| 19:8842783:C:G | F35L | 0.924 |
| 19:8843173:A:C | R165S | 0.914 |
| 19:8843173:A:T | R165S | 0.914 |
| 19:8842765:A:C | R29S | 0.903 |
| 19:8842765:A:T | R29S | 0.903 |
| 19:8843149:G:C | Q157H | 0.850 |
| 19:8843149:G:T | Q157H | 0.850 |
| 19:8843189:G:C | A171P | 0.839 |
| 19:8842772:A:C | S32R | 0.838 |
| 19:8842774:T:A | S32R | 0.838 |
| 19:8842774:T:G | S32R | 0.838 |
| 19:8843124:T:A | V149D | 0.831 |
| 19:8842794:T:A | V39E | 0.819 |
| 19:8842888:A:C | R70S | 0.817 |
| 19:8842888:A:T | R70S | 0.817 |
| 19:8843181:T:C | L168P | 0.816 |
| 19:8842764:G:C | R29T | 0.806 |
| 19:8843181:T:A | L168H | 0.799 |
| 19:8842770:C:T | S31F | 0.798 |
| 19:8843193:T:C | L172P | 0.795 |
| 19:8843172:G:T | R165I | 0.790 |
| 19:8842803:T:C | I42T | 0.785 |
| 19:8842803:T:G | I42S | 0.783 |
| 19:8842786:G:C | K36N | 0.777 |
| 19:8842786:G:T | K36N | 0.777 |
| 19:8842877:T:A | W67R | 0.777 |
| 19:8842877:T:C | W67R | 0.777 |
| 19:8842870:G:C | Q64H | 0.776 |
dbSNP variants (sampled 300 via entrez): RS1000158420 (19:8835918 C>A,T), RS1000201811 (19:8838878 A>G), RS1000459045 (19:8833545 GTC>G), RS1000577804 (19:8836523 G>A), RS1000726641 (19:8830994 T>C), RS1000831242 (19:8833342 A>G,T), RS1000906547 (19:8836711 C>T), RS1001503414 (19:8838064 T>C), RS1001695950 (19:8832513 A>G), RS1001971467 (19:8843423 C>A), RS1002043287 (19:8832152 T>G), RS1002054435 (19:8843247 G>A), RS1002268923 (19:8834239 A>C,G), RS1002500572 (19:8839309 T>C), RS1002521575 (19:8836931 G>A)
Disease associations
OMIM: gene MIM:607963 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| perfluorooctanoic acid | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.